These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7743532)

  • 1. Drug formularies--good or evil? A view from a managed care provider.
    Giaquinta D
    Cardiology; 1994; 85 Suppl 1():30-5. PubMed ID: 7743532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most?
    Glassman PA; Good CB; Kelley ME; Bradley M; Valentino M
    Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK; Sause RB; Zacker C
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drug formularies in managed care: concerns for the elderly population.
    Gross DJ
    Clin Ther; 1998; 20(6):1277-91. PubMed ID: 9916619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bitter pill: formulary variability and the challenge to prescribing physicians.
    Shrank WH; Ettner SL; Glassman P; Asch SM
    J Am Board Fam Pract; 2004; 17(6):401-7. PubMed ID: 15575031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization.
    Happe LE; Clark D; Holliday E; Young T
    J Manag Care Spec Pharm; 2014 Jul; 20(7):677-84. PubMed ID: 24967521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary management in the Department of Defense.
    Trice S; Devine J; Mistry H; Moore E; Linton A
    J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug formularies--good or evil? A view from the EEC.
    de Smedt M
    Cardiology; 1994; 85 Suppl 1():41-5. PubMed ID: 7743534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report.
    Fry RN; Avey SG; Sullivan SD
    Value Health; 2003; 6(5):505-21. PubMed ID: 14627057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug formularies--good or evil? The clinical perspective.
    Woodhouse KW
    Cardiology; 1994; 85 Suppl 1():36-40. PubMed ID: 7743533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of drug formularies in managed care.
    Hill LA
    J Hosp Mark; 1999; 13(2):63-85. PubMed ID: 10915392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organization.
    Meissner B; Dickson M; Shinogle J; Reeder CE; Belazi D; Senevirante V
    J Manag Care Pharm; 2006 May; 12(4):331-40. PubMed ID: 16792439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formularies in integrated health systems: Sharp HealthCare.
    Rizos AL; Levy E; Furnier J; Crowley K
    J Healthc Resour Manag; 1996 Sep; 14(7):14-9. PubMed ID: 10161585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternate financial incentives in multi-tiered formulary systems to improve accountability for outcomes.
    Chung RS; Taira DA; Noh C
    J Manag Care Pharm; 2003; 9(4):360-5. PubMed ID: 14613455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of an outpatient prescription drug formulary in a managed-care system.
    Black J; Griffin T; Beisel NW; Bartels MD
    Am J Hosp Pharm; 1988 Mar; 45(3):561-5. PubMed ID: 3130754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of formularies on clinical innovation.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 17():11-4. PubMed ID: 14680421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.